Health Span: a Nifty Measure
One of the striking things about people who live to very old ages is how spry and healthy many are until close to the end. There are exceptions of course,…
Memo to USPSTF: Hire A P.R. Pro
Last Friday at 3 p.m., the Agency for Healthcare Research and Quality held a telephone briefing to inform the press and public about the U.S. Preventive Services Task Force recommendation…
Can a Blood Test Really Tell You When You’ll Die?
As a taxi takes me across Madrid to the laboratories of Spain’s National Cancer Research Centre, I am fretting about the future. I am one of the first people in…
World Diabetes Day – Blue Fridays
Created by the awesome Cherise and edited by the equally awesome Kim.. Created by the awesome Cherise and edited by the equally awesome Kim.. Blue Fridays is an initiative to…
Social Media Summit at Mayo Clinic: Day One Exclusive Report
The Third Annual Social Media Summit at Mayo Clinic kicked off Sunday with pre-conference sessions attended by hundreds of folks. I’ve made the pilgrimage to Rochester, Minnesota, as a member…
Top Ten Medical Innovations: Cleveland Clinic Summit Takeaway
This year, the Cleveland Clinic Medical Innovation Summit focused on Cardiovascular Technologies, State of the Heart. The summit consisted of three days of stimulating presentations and panel discussions moderated by television ancho This…
Health eVillages: mHealth Tools for Underserved Regions Worldwide (podcast)
Physicians Interactive Holdings and the Robert F. Kennedy Center for Justice and Human Rights have launched Health eVillages, a consortium that has so far brought mobile medical tools to Kenya,…
Why Not A Nurse?
After Hurricane Katrina hit New Orleans, several hundred thousand refugees descended on Dallas, Houston and other Texas cities. Many of them needed medical care. Unfortunately, Texas wasn’t prepared. …
VIVUS, Inc., Presses the Case for Obesity Drug Qnexa, Market Success
Qnexa, a drug in development by VIVUS, is one of several promising drugs for the treatment of obesity that received adverse FDA decisions, but which are now receiving additional consideration…
VIVUS, Inc., Presses the Case for Obesity Drug Qnexa, Market Success
Qnexa, a drug in development by VIVUS, is one of several promising drugs for the treatment of obesity that received adverse FDA decisions, but which are now receiving additional consideration…
